ALS drug brings payoff
Knopp Neurosciences and Biogen Idec deal could provide up to $345 million in funding to the South Side biopharmaceutical development company and boost biotech in the region. Two local tech investors who originally backed the South Side company are Innovation Works and LaunchCyte LLC.
Read more in the Pittsburgh Post-Gazette
